Glucosamine infusion in rats mimics the β-cell dysfunction of non—insulin-dependent diabetes mellitus
- 1 May 1998
- journal article
- Published by Elsevier in Metabolism
- Vol. 47 (5) , 573-577
- https://doi.org/10.1016/s0026-0495(98)90242-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.Journal of Clinical Investigation, 1995
- In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.Journal of Clinical Investigation, 1995
- Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in ratsDiabetes, 1994
- Arginine-Induced Insulin Release in Glucokinase-Deficient SubjectsDiabetes Care, 1994
- Pathogenesis of non-insulin-dependent diabetes mellitusThe Lancet, 1994
- Glucosamine-induced desensitization of beta-cell responses: possible involvement of impaired information flow in the phosphoinositide cycleEndocrinology, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetesDiabetes, 1991
- Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.Journal of Clinical Investigation, 1988
- Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1984